Cargando…

Interpreting Adverse Signals in Diabetes Drug Development Programs

Detection and interpretation of adverse signals during preclinical and clinical stages of drug development inform the benefit-risk assessment that determines suitability for use in real-world situations. This review considers some recent signals associated with diabetes therapies, illustrating the d...

Descripción completa

Detalles Bibliográficos
Autor principal: Bailey, Clifford J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687324/
https://www.ncbi.nlm.nih.gov/pubmed/23695817
http://dx.doi.org/10.2337/dc13-0182

Ejemplares similares